Na Joo-Young
Biomedical Research Institute, Chonnam National University Hospital, 42, Jebong-ro, Dong-gu, Gwangju, 61469, Republic of Korea.
Forensic Sci Med Pathol. 2018 Sep;14(3):322-326. doi: 10.1007/s12024-018-9978-6. Epub 2018 Apr 25.
Glycated hemoglobin (HbA1c) is a good marker for monitoring glycemic control, and an elevated postmortem blood HbA1c level might indicate poor glycemic control during the antemortem period. The HbA1c level can be measured as a point-of-care (POC) test. In forensic medicine, POC testing is useful for performing autopsies and postmortem inspections since POC testing is both rapid and efficient. This study evaluated HbA1c levels in the capillary and cardiac venous blood of postmortem specimens as well as the usefulness of evaluating HbA1c levels as POC testing in postmortem examinations. For HbA1c testing performed on 103 autopsy cases, a portable SD A1cCare (test) was used for the POC testing, along with a Cobas Integra 800 (comparative). There was a strong correlation between HbA1c levels from postmortem capillary and cardiac venous blood (regression equation, 0.000 + 1.000×), and between HbA1c levels of cardiac venous blood measured using the portable SD A1cCare as a POC test and the Cobas Integra 800 (regression equation, -0.532 + 1.080×). HbA1c levels measured up to 4 weeks following the autopsy with the SD A1cCare had a tendency to decline. The author concluded that HbA1c POC testing can be used during postmortem inspection and during autopsy to accurately identify patients who had uncontrolled diabetes mellitus.
糖化血红蛋白(HbA1c)是监测血糖控制的良好指标,死后血液中HbA1c水平升高可能表明生前血糖控制不佳。HbA1c水平可作为即时检验(POC)进行检测。在法医学中,POC检测对于尸检和死后检查很有用,因为POC检测既快速又高效。本研究评估了死后标本的毛细血管血和心脏静脉血中的HbA1c水平,以及在死后检查中将评估HbA1c水平作为POC检测的实用性。对于在103例尸检病例上进行的HbA1c检测,使用便携式SD A1cCare(检测)进行POC检测,并与Cobas Integra 800(作为对照)一起使用。死后毛细血管血和心脏静脉血的HbA1c水平之间存在很强的相关性(回归方程,0.000 + 1.000×),并且使用便携式SD A1cCare作为POC检测测量的心脏静脉血的HbA1c水平与Cobas Integra 800之间也存在很强的相关性(回归方程,-0.532 + 1.080×)。使用SD A1cCare在尸检后长达4周测量的HbA1c水平有下降趋势。作者得出结论,HbA1c POC检测可用于死后检查和尸检期间,以准确识别患有未控制糖尿病的患者。